These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 5058306)
41. Serum enzymes after cardiac surgery using cardiopulmonary bypass. Neutze JM; Drakeley MJ; Barratt-Boyes BG; Hubbert K Am Heart J; 1974 Oct; 88(4):425-42. PubMed ID: 4415740 [No Abstract] [Full Text] [Related]
42. [Metabolic changes in the myocardium under the conditions of experimental ventricular fibrillation during extracorporeal circulation in the dog]. Stadelmann G; Kühn I; Djoulfajan O; Holec V; Fedelesova M; Ziegelhöffer A Thoraxchir Vask Chir; 1967 Aug; 15(4):447-56. PubMed ID: 5244171 [No Abstract] [Full Text] [Related]
43. Effects of pulsatile and nonpulsatile coronary perfusion on performance of the canine left ventricle. Habal SM; Weiss MB; Spotnitz HM; Parodi EN; Wolff M; Cannon PJ; Hoffman BF; Malm JR J Thorac Cardiovasc Surg; 1976 Nov; 72(5):742-55. PubMed ID: 979315 [TBL] [Abstract][Full Text] [Related]
44. Optimal levels of coronary perfusion pressure during cardiopulmonary bypass. Sokol DM; Mundth ED; Austen WG Surg Forum; 1969; 20():173-5. PubMed ID: 5383040 [No Abstract] [Full Text] [Related]
45. [The effects of left ventricular distention on coronary blood flow and myocardial metabolism during cardiopulmonary bypass (author's transl)]. Hottenrott C; Buckberg G; Maloney JV Thoraxchir Vask Chir; 1975 Jun; 23(3):298-300. PubMed ID: 1080607 [TBL] [Abstract][Full Text] [Related]
46. Effect of isoproterenol on ventricular work and myocardial metabolism in the postoperative heart. Mueller H; Giannelli S; Ayres SM; Conklin EF; Gregory JJ Circulation; 1968 Apr; 37(4 Suppl):II146-53. PubMed ID: 5646574 [No Abstract] [Full Text] [Related]
47. Effects of isoproterenol on hemodynamic alterations, myocardial metabolism, and coronary flow in experimental acute myocardial infarction with shock. Kuhn LA; Kline HJ; Goodman P; Johnson CD; Marano AJ Am Heart J; 1969 Jun; 77(6):772-83. PubMed ID: 5770150 [No Abstract] [Full Text] [Related]
48. Effects of selective left ventricular bypass on the left ventricular excess lactate and redox-potential. Yamamura N Jpn Circ J; 1968 Apr; 32(4):525-46. PubMed ID: 5695342 [No Abstract] [Full Text] [Related]
50. [Postoperative echocardiographic follow-up in patients with mitral and aortic valve disease (author's transl)]. Haerten K; Köhler E; Völz G; Herzer JA Z Kardiol; 1979 May; 68(5):357-66. PubMed ID: 463193 [No Abstract] [Full Text] [Related]
51. [Long-term results in heart-valve surgery]. Rothlin M; Messmer BJ; Senning A Schweiz Med Wochenschr; 1973 Apr; 103(17):617-21. PubMed ID: 4704803 [No Abstract] [Full Text] [Related]
52. [Experimental study on electrical ventricular fibrillation as a method for prolonged cardiac arrest: with special reference to myocardial metabolism]. Omori S Jpn Circ J; 1972 Jan; 36(1):71-91. PubMed ID: 5067906 [No Abstract] [Full Text] [Related]
53. The effects of elevated red blood cell 2,3-diphosphoglycerate concentration on myocardial oxygenation and metabolism during cardiopulmonary bypass. Jalonen J; Rajamäki A; Laaksonen V; Inberg MV J Thorac Cardiovasc Surg; 1980 May; 79(5):748-54. PubMed ID: 7366241 [No Abstract] [Full Text] [Related]
54. Coronary hemodynamics and regional myocardial metabolism in experimental aortic insufficiency. Griggs DM; Chen CC J Clin Invest; 1974 Jun; 53(6):1599-606. PubMed ID: 4830224 [TBL] [Abstract][Full Text] [Related]
55. [Recurrent ventricular fibrillation and ST segment elevation in the right precordial leads due to acute occlusion of the conus branch]. Hernández Hernández F; Barrios Garrido-Lestache E; Arribas P; Gutierrez J Rev Esp Cardiol; 2011 Dec; 64(12):1226-7. PubMed ID: 21676521 [No Abstract] [Full Text] [Related]
56. Determinants of left ventricular hypertrophy and oxygen supply in chronic aortic valve disease. Trenouth RS; Phelps NC; Neill WA Circulation; 1976 Apr; 53(4):644-50. PubMed ID: 130213 [TBL] [Abstract][Full Text] [Related]
57. [When is surgery needed for minimally symptomatic or asymptomatic acquired valvulopathy?]. Acar J; Michel PL; de Gevigney G Presse Med; 2000 Nov; 29(34):1867-75. PubMed ID: 11709821 [TBL] [Abstract][Full Text] [Related]